nimodipine |
66085-59-4 |
Nimotop |
Periplum |
Nimodipino |
Admon |
Nimodipinum |
Bay-E 9736 |
Nimodipinum INN-Latin |
Nimodipino INN-Spanish |
BAY e 9736 |
Bay-e-9736 |
3-isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate |
CHEBI:7575 |
Nimodipine (Nimotop) |
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester |
C21H26N2O7 |
MLS000863294 |
3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Nymalize |
MFCD00153848 |
3-(2-methoxyethyl) 5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
NCGC00015714-09 |
SMR000058300 |
DSSTox_CID_3370 |
DSSTox_RID_76998 |
isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate |
DSSTox_GSID_23370 |
2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
NimoGel |
DRG-0139 |
Nimotop(TM) |
1-methylethyl 2-(methyloxy)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester |
SR-01000075335 |
NIMOTOP (TN) |
EINECS 266-127-0 |
BRN 0459792 |
NimoVent |
Nimodipime,(S) |
Nimodipine USAN:USP:INN:BAN |
Nymalize (TN) |
CAS-66085-59-4 |
EG-1961 |
Opera_ID_14 |
Spectrum_001880 |
SpecPlus_000716 |
Nimodipine (USP/INN) |
Prestwick0_000918 |
Prestwick1_000918 |
Prestwick2_000918 |
Prestwick3_000918 |
Spectrum2_001562 |
Spectrum3_000766 |
Spectrum4_000791 |
Spectrum5_001687 |
N-149 |
CBiol_001832 |
Lopac0_000891 |
SCHEMBL34041 |
BSPBio_000796 |
BSPBio_001397 |
BSPBio_002412 |
KBioGR_000117 |
KBioGR_001262 |
KBioSS_000117 |
KBioSS_002408 |
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-methoxyethyl 1-methylethyl ester |
MLS000069381 |
MLS001076550 |
MLS001424155 |
MLS002154061 |
MLS002172461 |
MLS003899190 |
DivK1c_006812 |
SPECTRUM1503600 |
SPBio_001464 |
SPBio_002985 |
BPBio1_000876 |
GTPL2523 |
CHEMBL3197349 |
DTXSID5023370 |
SCHEMBL22882841 |
KBio1_001756 |
KBio2_000117 |
KBio2_002403 |
KBio2_002685 |
KBio2_004971 |
KBio2_005253 |
KBio2_007539 |
KBio3_000233 |
KBio3_000234 |
KBio3_001632 |
3-isopropyl 5-(2-methoxyethyl) |
BRD8407 |
Bio1_000118 |
Bio1_000607 |
Bio1_001096 |
Bio2_000117 |
Bio2_000597 |
HMS1361F19 |
HMS1570H18 |
HMS1791F19 |
HMS1922E04 |
HMS1989F19 |
HMS2052M05 |
HMS2089H13 |
HMS2093G11 |
HMS2097H18 |
HMS2234B05 |
HMS3262D04 |
HMS3266O22 |
HMS3369G07 |
HMS3394M05 |
HMS3402F19 |
HMS3411I12 |
HMS3657I03 |
HMS3675I12 |
HMS3714H18 |
Pharmakon1600-01503600 |
3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester |
ACT02628 |
ALBB-015317 |
AMY40399 |
BCP21152 |
BRD-8407 |
HY-B0265 |
2,6-dimethyl-4-(3-nitrophenyl)- |
Nimotop|||Admon|||BAY-e 9736 |
Tox21_110202 |
Tox21_500891 |
BBL028286 |
BDBM50101971 |
CA-211 |
CCG-39340 |
NSC758476 |
s1747 |
STK642934 |
AKOS005174934 |
AKOS015852459 |
Nimodipine - CAS 66085-59-4 |
Tox21_110202_1 |
AC-8484 |
CCG-101085 |
DB00393 |
KS-1304 |
LP00891 |
MCULE-4717687158 |
NC00335 |
NSC 758476 |
NSC-758476 |
SDCCGSBI-0050866.P004 |
IDI1_033867 |
isopropyl 2-methoxyethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
NCGC00015714-04 |
NCGC00015714-05 |
NCGC00015714-06 |
NCGC00015714-07 |
NCGC00015714-08 |
NCGC00015714-10 |
NCGC00015714-11 |
NCGC00015714-12 |
NCGC00015714-13 |
NCGC00015714-16 |
NCGC00015714-28 |
NCGC00021456-02 |
NCGC00024675-02 |
NCGC00024675-03 |
NCGC00024675-04 |
NCGC00024675-05 |
NCGC00024675-06 |
NCGC00024675-07 |
NCGC00024675-08 |
NCGC00024675-09 |
NCGC00261576-01 |
1,4-Dihydro-2,6-dimethyl-4-(3′-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl Ester |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester |
Nimodipine 100 microg/mL in Acetonitrile |
O5-isopropyl O3-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
SMR002530605 |
ST082783 |
SBI-0050866.P003 |
AB0012346 |
AB00513963 |
EU-0100891 |
FT-0602600 |
N0896 |
SW219238-1 |
C07267 |
D00438 |
F20554 |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)- |
AB00053314-03 |
AB00053314-04 |
AB00053314_05 |
AB00053314_06 |
085N594 |
Q421429 |
SR-01000075335-1 |
SR-01000075335-2 |
SR-01000075335-4 |
SR-01000075335-5 |
SR-01000075335-7 |
BRD-A58048407-001-06-3 |
BRD-A58048407-001-09-7 |
BAY E 9736 pound>> BAY-E-9736 pound>> BAYE97 |
Nimodipine, British Pharmacopoeia (BP) Reference Standard |
Nimodipine, European Pharmacopoeia (EP) Reference Standard |
Nimodipine, United States Pharmacopeia (USP) Reference Standard |
Nimodipine, Pharmaceutical Secondary Standard; Certified Reference Material |
Nimodipine for peak identification, EuropePharmacopoeia (EP) Reference Standard |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methyloxyethyl 1-methylethyl ester |
2-Methoxyethyl 1-Methylethyl 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate |
3-Isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate # |
isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate |
methylethyl 5-(2-methoxyethyl)oxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4 -dihydropyridine-3-carboxylate |
O5-(2-methoxyethyl) O3-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |